Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Selective versus stepwise removal of deep carious lesions in permanent teeth: a randomised controlled trial from Egypt-an interim analysis.

Labib ME, Hassanein OE, Moussa M, Yassen A, Schwendicke F.

BMJ Open. 2019 Sep 17;9(9):e030957. doi: 10.1136/bmjopen-2019-030957.

2.

BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics.

Thomas D, Thelen K, Kraff S, Schwers S, Schiffer S, Unger S, Yassen A, Boxnick S.

Res Pract Thromb Haemost. 2019 Feb 14;3(2):242-253. doi: 10.1002/rth2.12186. eCollection 2019 Apr.

3.

Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases.

Abdel-Khalek EE, Alrefaey AK, Yassen AM, Monier A, Elgouhari HM, Habl MS, Tawfik G, Elzayat T, Zayed RA, Abdel-Wahab M.

J Transplant. 2018 Dec 23;2018:5910372. doi: 10.1155/2018/5910372. eCollection 2018.

4.

Adrenalectomy for solitary recurrent hepatocellular carcinoma five years after living donor liver transplantation: A case report.

Abdel Wahab M, Shehta A, Ibrahim EM, Eldesoky RT, Sultan AA, Zalata KR, Fathy O, Elshoubary M, Salah T, Yassen AM, Elmorshedi M, Monier A, Farouk A, Shiha U.

Int J Surg Case Rep. 2019;54:23-27. doi: 10.1016/j.ijscr.2018.11.062. Epub 2018 Nov 27.

5.

Influence of gamma radiation on microshear bond strength and nanoleakage of nanofilled restoratives in Er, Cr:YSGG laser-prepared cavities.

Abaza EF, Zaki AA, Moharram HS, Batouti AAEDE, Yassen AA.

Eur J Dent. 2018 Jul-Sep;12(3):338-343. doi: 10.4103/ejd.ejd_305_17.

6.

Outcomes of Living Donor Liver Transplantation for Patients with Preoperative Portal Vein Problems.

Wahab MA, Shehta A, Elshoubary M, Salah T, Fathy O, Sultan A, Elghawalby AN, Ali M, Yassen AM, Elmorshedi M, Eldesoky M, Monier A, Said R.

J Gastrointest Surg. 2018 Dec;22(12):2055-2063. doi: 10.1007/s11605-018-3876-9. Epub 2018 Jul 23.

PMID:
30039445
7.

Internal hernia of the small intestine around biliary catheter after living-donor liver transplantation: A case report.

Abdel Wahab M, Shehta A, Adly R, Elshoubary M, Salah T, Yassen AM, Elmorshedi M, Emara MM, Abdelkhalek M, Elsedeiq M, Shiha U, Elghawalby AN, Eldesoky M, Monier A, Said R.

Int J Surg Case Rep. 2018;49:158-162. doi: 10.1016/j.ijscr.2018.06.023. Epub 2018 Jun 28.

8.

Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.

Wahab MA, Shehta A, Elshoubary M, Yassen AM, Elmorshedi M, Salah T, Sultan AM, Fathy O, Elsarraf WR, Shiha U, Zalata K, Elghawalby AN, Eldesoky M, Monier A, Said R, Elsabagh AM, Ali M, Kandeel A, Abdalla U, Aboelella M, Elsadany M, Abdel-Khalek EE, Marwan A, ElMorsi FM, Adly R.

Transplant Proc. 2018 Jun;50(5):1396-1406. doi: 10.1016/j.transproceed.2018.02.085. Epub 2018 Mar 10.

PMID:
29880362
9.

Predictive Factors of Liver Dysfunction After Right Hemihepatectomy for Adult Living Donor Liver Transplantation.

Elshoubary M, Shehta A, Salah T, Sultan AM, Yassen AM, Abdulrazek M, El-Magd EA, Elghawalby AN, Shiha U, Elmorshedi M, Elsadany M, Abdelkhalek E, Fathy O, Wahab MA.

Transplant Proc. 2018 May;50(4):1114-1122. doi: 10.1016/j.transproceed.2017.11.077.

PMID:
29731077
10.

Dexmedetomidine in a surgically inserted catheter for transversus abdominis plane block in donor hepatectomy: A prospective randomized controlled study.

Aboelela MA, Kandeel AR, Elsayed U, Elmorshedi M, Elsarraf W, Elsayed E, Elgawalby A, Sultan AM, Wahab MA, Yassen A.

Saudi J Anaesth. 2018 Apr-Jun;12(2):297-303. doi: 10.4103/sja.SJA_577_17. Retraction in: Saudi J Anaesth. 2019 Apr-Jun;13(2):175.

12.

Predictors of hepatitis C virus recurrence after living donor liver transplantation: Mansoura experience.

Abdel-Wahab M, Abdel-Khalek EE, El-Gilany AH, Yassen AM, Al-Shobari M, Shiha U, Ali M, Sadani M, Salah T, Sultan AM, Elghawalby AN, Elmorshedi M, Al-Refaey AK, Abdalla U.

Arab J Gastroenterol. 2017 Sep;18(3):151-155. doi: 10.1016/j.ajg.2017.09.006. Epub 2017 Sep 22.

PMID:
28958486
13.

Early-Onset Pneumonia After Liver Transplant: Microbial Causes, Risk Factors, and Outcomes, Mansoura University, Egypt, Experience.

El-Badrawy MK, Ali RE, Yassen A, AbouElela MA, Elmorsey RA.

Exp Clin Transplant. 2017 Oct;15(5):547-553. doi: 10.6002/ect.2016.0176. Epub 2017 Jul 11.

14.

High Survival and Mortality Characteristics in Heart Transplant Patients at a National Institute.

Rojas C, De la Cruz-Ku G, Yassen A, Valcarcel-Valdivia B.

Exp Clin Transplant. 2018 Feb;16(1):68-74. doi: 10.6002/ect.2016.0230. Epub 2017 Jul 11.

15.

Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A prospective randomized controlled trial.

Yassen AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, Salah T, Sultan AM, Elghawalby AN, Elshobari MM, Elsadany M, Zalata K, Shiha U.

Transpl Int. 2017 Jul;30(7):725-733. doi: 10.1111/tri.12968.

16.

Spray Diathermy Versus Harmonic Scalpel Technique for Hepatic Parenchymal Transection of Living Donor.

El Shobary M, Salah T, El Nakeeb A, Sultan AM, Elghawalby A, Fathy O, Wahab MA, Yassen A, Elmorshedy M, Elkashef WF, Shiha U, Elsadany M.

J Gastrointest Surg. 2017 Feb;21(2):321-329. doi: 10.1007/s11605-016-3312-y. Epub 2016 Oct 31.

PMID:
27798785
17.

Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis.

Schatz A, Trankle C, Yassen A, Chipko C, Rajab M, Abouzaki N, Abbate A.

Int J Cardiol. 2016 Nov 15;223:215-216. doi: 10.1016/j.ijcard.2016.08.131. Epub 2016 Aug 7. No abstract available.

PMID:
27541656
18.

Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.

Ali MA, Elshobari MM, Salah T, Kandeel AR, Sultan AM, Elghawalby AN, Shehta A, Elsayed U, Fathy O, Yassen A, Wahab MA.

Liver Transpl. 2017 Jan;23(1):43-49. doi: 10.1002/lt.24599.

20.

Hepatic venous outflow obstruction after living donor liver transplantation managed with ectopic placement of a foley catheter: A case report.

Wahab MA, Shehta A, Hamed H, Elshobary M, Salah T, Sultan AM, Fathy O, Elghawalby A, Yassen A, Shiha U.

Int J Surg Case Rep. 2015;10:65-8. doi: 10.1016/j.ijscr.2015.03.017. Epub 2015 Mar 12.

21.

Epidemiology of neural tube defects in Saudi Arabia.

AlShail E, De Vol E, Yassen A, Elgamal EA.

Saudi Med J. 2014 Dec;35 Suppl 1:S68-71.

22.

Problem of living liver donation in the absence of deceased liver transplantation program: Mansoura experience.

Wahab MA, Hamed H, Salah T, Elsarraf W, Elshobary M, Sultan AM, Shehta A, Fathy O, Ezzat H, Yassen A, Elmorshedi M, Elsaadany M, Shiha U.

World J Gastroenterol. 2014 Oct 7;20(37):13607-14. doi: 10.3748/wjg.v20.i37.13607.

23.

Biliary complications in living donor right hepatectomy are affected by the method of bile duct division.

Sultan AM, Salah T, Elshobary MM, Fathy OM, Elghawalby AN, Yassen AM, Elmorshedy MA, Elsadany MF, Shiha UA, Wahab MA.

Liver Transpl. 2014 Nov;20(11):1393-401. doi: 10.1002/lt.23964.

24.

Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents.

Yassen AS, Elshihawy HE, Said MM, Abouzid KA.

Chem Pharm Bull (Tokyo). 2014;62(5):454-66.

25.

Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.

Abdel-Wahab M, Sultan AM, Fathy OM, Salah T, Elshobary MM, Elghawalby NA, Yassen AM, Elsarraf WM, Elsaadany MF, Zalatah K.

Hepatogastroenterology. 2013 Nov-Dec;60(128):1847-53.

PMID:
24719918
26.

Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages.

Strougo A, Yassen A, Monnereau C, Danhof M, Freijer J.

J Clin Pharmacol. 2014 Sep;54(9):1006-15. doi: 10.1002/jcph.294. Epub 2014 Mar 28.

PMID:
24676942
27.

A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.

Martini CH, Yassen A, Krebs-Brown A, Passier P, Stoker M, Olofsen E, Dahan A.

Eur J Pain. 2013 Nov;17(10):1491-501. doi: 10.1002/j.1532-2149.2013.00329.x. Epub 2013 May 6.

PMID:
23650124
28.

In response.

Yassen AM, Elsarraf WR, Elshobari MM, Salah T, Sultan AM, Elsadany M.

Anesth Analg. 2013 Mar;116(3):738. No abstract available.

PMID:
23560323
29.

Translational PK-PD modeling in pain.

Yassen A, Passier P, Furuichi Y, Dahan A.

J Pharmacokinet Pharmacodyn. 2013 Jun;40(3):401-18. doi: 10.1007/s10928-012-9282-0. Epub 2012 Nov 30. Review.

PMID:
23197248
30.

Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective.

Bonate PL, Strougo A, Desai A, Roy M, Yassen A, van der Walt JS, Kaibara A, Tannenbaum S.

AAPS J. 2012 Dec;14(4):749-58. doi: 10.1208/s12248-012-9387-9. Epub 2012 Jul 24. Review.

31.

The impact of portopulmonary hypertension on intraoperative right ventricular function of living donor liver transplant recipients.

Yassen AM, Elsarraf WR, Elsadany M, Elshobari MM, Salah T, Sultan AM.

Anesth Analg. 2012 Sep;115(3):689-93. doi: 10.1213/ANE.0b013e318261f6d9. Epub 2012 Jun 28.

PMID:
22745118
32.

Alleviation of reproductive toxicity of gossypol using selenium supplementation in rams.

El-Mokadem MY, Taha TA, Samak MA, Yassen AM.

J Anim Sci. 2012 Sep;90(9):3274-85. doi: 10.2527/jas.2011-4545. Epub 2012 May 14.

PMID:
22585803
33.

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups.

Martini C, Yassen A, Olofsen E, Passier P, Stoker M, Dahan A.

J Pain Res. 2012;5:51-9. doi: 10.2147/JPR.S30406. Epub 2012 Mar 15.

34.

Outcome of right hepatectomy for living liver donors: a single Egyptian center experience.

Salah T, Sultan AM, Fathy OM, Elshobary MM, Elghawalby NA, Sultan A, Yassen AM, Elsarraf WM, Elmorshedi M, Elsaadany MF, Shiha UA, Wahab MA.

J Gastrointest Surg. 2012 Jun;16(6):1181-8. doi: 10.1007/s11605-012-1851-4. Epub 2012 Feb 28.

PMID:
22370735
35.

First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development.

Strougo A, Eissing T, Yassen A, Willmann S, Danhof M, Freijer J.

J Pharmacokinet Pharmacodyn. 2012 Apr;39(2):195-203. doi: 10.1007/s10928-012-9241-9. Epub 2012 Feb 5.

36.

Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature.

Martini C, Olofsen E, Yassen A, Aarts L, Dahan A.

Expert Rev Clin Pharmacol. 2011 Nov;4(6):719-28. doi: 10.1586/ecp.11.59. Review.

PMID:
22111858
37.

A semiphysiological population model for prediction of the pharmacokinetics of drugs under liver and renal disease conditions.

Strougo A, Yassen A, Krauwinkel W, Danhof M, Freijer J.

Drug Metab Dispos. 2011 Jul;39(7):1278-87. doi: 10.1124/dmd.110.037838. Epub 2011 Apr 12. Erratum in: Drug Metab Dispos. 2012 Jul;40(7):1449.

PMID:
21487054
38.

Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.

Yassen A, Olofsen E, van Dorp E, Sarton E, Teppema L, Danhof M, Dahan A.

Clin Pharmacokinet. 2007;46(11):965-80.

PMID:
17922561
39.

Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats.

Yassen A, Olofsen E, Kan J, Dahan A, Danhof M.

Pharm Res. 2008 Jan;25(1):183-93. Epub 2007 Oct 4.

40.

Morphine-6-glucuronide (M6G) for postoperative pain relief.

Dahan A, van Dorp E, Smith T, Yassen A.

Eur J Pain. 2008 May;12(4):403-11. Epub 2007 Sep 14. Review.

PMID:
17869146
41.

Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine.

Yassen A, Olofsen E, Kan J, Dahan A, Danhof M.

Clin Pharmacokinet. 2007;46(5):433-47.

PMID:
17465641
42.

Naloxone treatment in opioid addiction: the risks and benefits.

van Dorp E, Yassen A, Dahan A.

Expert Opin Drug Saf. 2007 Mar;6(2):125-32. Review.

PMID:
17367258
43.

Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats.

Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M.

J Pharmacol Exp Ther. 2007 May;321(2):598-607. Epub 2007 Feb 5.

PMID:
17283225
44.

Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers.

Yassen A, Olofsen E, Romberg R, Sarton E, Teppema L, Danhof M, Dahan A.

Clin Pharmacol Ther. 2007 Jan;81(1):50-8.

PMID:
17185999
45.

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats.

Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M.

J Pharmacol Exp Ther. 2006 Nov;319(2):682-92. Epub 2006 Jul 19.

PMID:
16855177
46.

Naloxone reversal of buprenorphine-induced respiratory depression.

van Dorp E, Yassen A, Sarton E, Romberg R, Olofsen E, Teppema L, Danhof M, Dahan A.

Anesthesiology. 2006 Jul;105(1):51-7.

PMID:
16809994
47.

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers.

Yassen A, Olofsen E, Romberg R, Sarton E, Danhof M, Dahan A.

Anesthesiology. 2006 Jun;104(6):1232-42.

PMID:
16732095
48.

Buprenorphine induces ceiling in respiratory depression but not in analgesia.

Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.

Br J Anaesth. 2006 May;96(5):627-32. Epub 2006 Mar 17.

49.

Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats.

Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.

Br J Anaesth. 2005 Jun;94(6):825-34. Epub 2005 Apr 15.

50.

Comparison of helicobacter pylori stool antigen test with CLO test in the diagnosis of helicobacter pylori associated dyspepsia in a Saudi population.

Osoba AO, Ibrahim MB, Al-Shareef BA, Yassen AA, Hussein BA.

Saudi Med J. 2004 Dec;25(12):1906-8.

PMID:
15711664

Supplemental Content

Loading ...
Support Center